Pharma is cool with patients if you are in the Science/Bio part of the company.
Weekly Company not so old. Consolidation of price Daily If price holds level of 57 could be buy, but i suppose profit depends on how fast they will do resarch of anticancer in 2022-2024 years.
Island type Reversal pattern on Abnormal Volume New 30bar Highs on 2period ROC Climactic action and supple demand imbalance Longer term Wolf wave pattern on Weeklys and Daily’s
Strong company Nice ratings Strong support I am long
Could be a runner today on the news that is has agreed to sell its cancer portfolio . "Servier will pay $1.8 billion in cash upfront and $200 million in potential future milestone payments for vorasidenib as well as a small percentage of royalties for U.S. net sales of acute myeloid leukemia treatment Tibsovo and U.S. net sales of vorasidenib, if the...
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley,...
Alert set for break above the 200MA. A cross above mid channel would be very bullish setting up a move to the top of channel. RSi very strong bounce of Mid-point Volume beginning to increase Short term target $46- $48
AGIO: Agios Pharmaceuticals, Inc. 2020-11-12 16:30:16 Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
Why get subbed to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates AGIO 8H: BEST Level to BUY/HOLD 90% gains(SL/TP)(STOCKS) IMPORTANT...
AGIO: Agios Pharmaceuticals, Inc. 2020-06-08 16:01:10 Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it...
Shares have made a very positive move afterhours on good volume after the release of its 8-K Inc announcing that the global phase 3 ClarIDHy trial of TIBSOVO® (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitrate dehydrogenase 1 mutation met its primary endpoint. Tomorrow will be a very positive day so be ready, it could move very...
The bullis trend has been turned with Head and Shoulders formation. The resistance trend line do not allow the price to grow, up to now touched that line 4. times. If it will not penetrate fifth time, that is a big chance to move down to 50$
This is a perfect opportunity to short this stock. Every singe Ichimoku indicator signifies that this is a perfect opportunity. It also signifies it will continue to drop for quite a while. The indicators used are: 1) Gann Fan 2) Kumo Cloud 3) Tenkan-Sen and Kijun-Sen 4) Chikou line is now free 5) Price-Volume Trendline 6) Stoch Index Disclaimer: I am just...